Product
Maintenance of immunosuppressive treatment: Imurel, Mabthera, Cellcept, Cortancyl
1 clinical trial
2 indications
Indication
ANCA-Associated VasculitisIndication
End-Stage Renal DiseaseClinical trial
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical TrialStatus: Recruiting, Estimated PCD: 2031-03-01